Insider Trading February 17, 2026

Saba Capital Reduces Stake in PIMCO Dynamic Income Strategy Fund with Two February Trades

Block sales totaled 105,702 shares across Feb. 12-13 as PDX continues to trade under the sale prices and shows solid year-to-date gains

By Derek Hwang PDX
Saba Capital Reduces Stake in PIMCO Dynamic Income Strategy Fund with Two February Trades
PDX

Saba Capital Management, L.P., identified as a ten-percent owner of PIMCO Dynamic Income Strategy Fund (NYSE: PDX), reported two sales of common stock on February 12 and 13, 2026. The firm disposed of 15,702 shares at $20.11 and 90,000 shares at $20.08, bringing total proceeds to $2,122,967. After the transactions, Saba indirectly holds 6,588,956 shares. PDX currently trades at $19.99, carries a 22.7% dividend yield per InvestingPro, and has delivered an 8.5% year-to-date return while maintaining an "EXCELLENT" financial health score and roughly $899 million market capitalization.

Key Points

  • Saba Capital sold 15,702 PDX shares at $20.11 on Feb. 12 and 90,000 shares at $20.08 on Feb. 13, 2026, totaling $2,122,967.
  • After these transactions, Saba indirectly holds 6,588,956 shares; PDX trades at $19.99 and shows an 8.5% year-to-date return.
  • InvestingPro reports a 22.7% dividend yield for PDX, an "EXCELLENT" financial health score, and a market cap of about $899 million.

Saba Capital Management, L.P. reported two executed sales of PIMCO Dynamic Income Strategy Fund common stock on February 12 and 13, 2026, according to a Form 4 filing with the Securities and Exchange Commission.

On February 12, Saba sold 15,702 shares of PDX at $20.11 per share. The following day, February 13, the firm sold an additional 90,000 shares at $20.08 per share. The combined value of those transactions amounted to $2,122,967.

Following the disposition, Saba Capital indirectly owns 6,588,956 shares of PIMCO Dynamic Income Strategy Fund. At the time of the filing, the fund was trading at $19.99 per share - below the prices at which the two blocks were sold.

InvestingPro data cited alongside the filing places the fund's annual dividend yield at 22.7% and records a year-to-date return of 8.5% for PDX. The platform also assigns PDX an "EXCELLENT" financial health score and notes the fund generally exhibits low price volatility. Market capitalization is listed at approximately $899 million.

The filing does not provide commentary from Saba Capital on its rationale for the sales, nor does it indicate any further changes to the firms remaining holdings beyond the updated share count.


Context for investors

The reported transactions represent a discrete reduction in Sabas exposure to PDX while leaving the firm with a substantial indirect holding. The sales prices on February 12 and 13 were both modestly above the fund's then-current trading price, and the record-high dividend yield noted by InvestingPro remains a prominent feature of the fund's profile.

Additional metrics and analytical insights into the funds profile are available through InvestingPros ProTips and comprehensive datasets referenced in the filing materials.

Risks

  • The sale prices of $20.08-$20.11 were higher than PDX's quoted trading price of $19.99, presenting near-term price disparity for holders and potential concerns for short-term investors.
  • The fund's reported 22.7% dividend yield is a prominent characteristic that investors will need to assess in light of price performance and distributions.
  • Saba Capital continues to hold a substantial indirect position of 6,588,956 shares, creating concentration considerations for ownership structure.

More from Insider Trading

Clean Harbors Director Executes $204,802 Sale as Company Reports Strong Q4 and Pushes M&A Agenda Feb 21, 2026 Clean Harbors Executive Disposes Nearly $1.0M in Stock as Company Posts Strong Q4 Feb 21, 2026 Clean Harbors CFO Disposes $784K in Shares as Company Reports Strong Quarter and Pursues Acquisition Feb 21, 2026 Travelers Executive Vice President Records $1.74 Million Share Sale as Company Posts Strong Quarter Feb 21, 2026 Genasys Director Buys $50,404 of Stock; Company Reports Mixed Q1 Results Feb 21, 2026